{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:21:28Z","timestamp":1789777288498,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>M2-polarized tumor-associated macrophages (TAMs) are a key factor contributing to the poor prognosis of pancreatic ductal adenocarcinoma (PDAC). While various factors within the tumor microenvironment (TME) drive their formation, the role of PDAC-derived exosomes in this process remains unclear. We aim to clarify the regulatory impacts of tumor-derived exosomes to TAMs. After the intratumoral injection to subcutaneous tumor of C57BL\/6 mice, we demonstrated PDAC-derived exosomes exacerbate PDAC progression, accompanied with upregulated M2 phenotype of TAMs and unaffected proliferation signatures. Through intratumoral injection model and multi-Omics analyses, we identified CCT6A as a novel tumor-derived exosomal protein, bridging TAMs M2 polarization and PDAC prognosis. Co-culture with exosomes derived from CCT6A<jats:sup>high<\/jats:sup> PDAC leads to greater M2 phenotype of TAMs via PI3K-AKT signaling. According to proteomics data, chemokines\u2019 abundance reduces over tenfold once exosomal CCT6A absence, including CXCL1, CXCL3, CCL20 and CCL5, whose interaction with CCT6A in PDAC cells was confirmed by interactomics data. Moreover, we found silencing CCT6A abrogated the antagonism effects of CD47 antibody immunotherapy. Our findings implied that the subunit of the T-complex protein Ring Complex (TRiC) CCT6A serves as a matchmaker during exosome-mediated chemokines transfer from PDAC to TAMs. Silencing CCT6A effectively sensitized PDAC to CD47 antibody immunotherapy in vivo.<\/jats:p>","DOI":"10.1038\/s41419-025-07720-y","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T12:58:08Z","timestamp":1747313888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Tianyin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Wa","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairang","family":"Dongzhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Gongye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5430-5024","authenticated-orcid":false,"given":"Zhiyong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0399-6005","authenticated-orcid":false,"given":"Weijie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4014-7392","authenticated-orcid":false,"given":"Ming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-3803","authenticated-orcid":false,"given":"Yufeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"7720_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"7720_CR2","doi-asserted-by":"publisher","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer. JAMA. 2021; 326. https:\/\/doi.org\/10.1001\/jama.2021.13027.","DOI":"10.1001\/jama.2021.13027"},{"key":"7720_CR3","doi-asserted-by":"publisher","unstructured":"Xu Q, Chen S, Hu Y, Huang W. Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma. Cancer Cell Int. 2021;21. https:\/\/doi.org\/10.1186\/s12935-021-02289-w.","DOI":"10.1186\/s12935-021-02289-w"},{"key":"7720_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66:605\u201312.","journal-title":"Cancer Res"},{"key":"7720_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature"},{"key":"7720_CR6","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","volume":"78","author":"X Wang","year":"2018","unstructured":"Wang X, Luo G, Zhang K, Cao J, Huang C, Jiang T, et al. Hypoxic Tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3K\u03b3 to promote pancreatic cancer metastasis. Cancer Res. 2018;78:4586\u201398.","journal-title":"Cancer Res"},{"key":"7720_CR7","doi-asserted-by":"publisher","unstructured":"Pan Y, Lu F, Fei Q, Yu X, Xiong P, Yu X, et al. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer. J Hematol Oncol. 2019;12. https:\/\/doi.org\/10.1186\/s13045-019-0822-6.","DOI":"10.1186\/s13045-019-0822-6"},{"key":"7720_CR8","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1158\/2159-8290.CD-22-1046","volume":"13","author":"A Bianchi","year":"2023","unstructured":"Bianchi A, De Castro Silva I, Deshpande NU, Singh S, Mehra S, Garrido VT, et al. Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer. Cancer Discov. 2023;13:1428\u201353.","journal-title":"Cancer Discov"},{"key":"7720_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1158\/2159-8290.CD-23-0584","volume":"14","author":"W Sang","year":"2024","unstructured":"Sang W, Zhou Y, Chen H, Yu C, Dai L, Liu Z, et al. Receptor-interacting protein kinase 2 is an immunotherapy target in pancreatic cancer. Cancer Discov. 2024;14:326\u201347.","journal-title":"Cancer Discov"},{"key":"7720_CR10","doi-asserted-by":"publisher","unstructured":"Chen L, Shi V, Wang S, Sun L, Freeman R, Yang J, et al. SCCA1\/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production. J Clin Invest. 2023;133. https:\/\/doi.org\/10.1172\/JCI163841.","DOI":"10.1172\/JCI163841"},{"key":"7720_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","volume":"42","author":"M Liu","year":"2024","unstructured":"Liu M, Ren Y, Zhou Z, Yang J, Shi X, Cai Y, et al. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Cancer Cell. 2024;42:885\u2013903.e4.","journal-title":"Cancer Cell"},{"key":"7720_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8:237\u201355.","journal-title":"Theranostics"},{"key":"7720_CR13","doi-asserted-by":"crossref","unstructured":"Luo Y, Li Z, Kong Y, He W, Zheng H, An M, et al. KRAS mutant\u2013driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer. J Clin Invest. 2022;132:e157644.","DOI":"10.1172\/JCI157644"},{"key":"7720_CR14","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1021\/acsnano.3c07002","volume":"18","author":"C Qu","year":"2024","unstructured":"Qu C, Yuan H, Tian M, Zhang X, Xia P, Shi G, et al. Precise photodynamic therapy by midkine nanobody-engineered nanoparticles remodels the microenvironment of pancreatic ductal adenocarcinoma and potentiates the immunotherapy. ACS Nano. 2024;18:4019\u201337.","journal-title":"ACS Nano"},{"key":"7720_CR15","doi-asserted-by":"publisher","first-page":"2401905","DOI":"10.1002\/advs.202401905","volume":"11","author":"X Xu","year":"2024","unstructured":"Xu X, Ding Y, Dong Y, Yuan H, Xia P, Qu C. et al. Nanobody-Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING-Mediated Anti-Tumor Immunity. Adv Sci. 2024;11:2401905.","journal-title":"Adv Sci"},{"key":"7720_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/HEP.0000000000000585","volume":"79","author":"T Wu","year":"2024","unstructured":"Wu T, Chen X, Xu K, Dai C, Li X, Zhang Y-W-Q, et al. LIM domain only 7 negatively controls nonalcoholic steatohepatitis in the setting of hyperlipidemia. Hepatology. 2024;79:149\u201366.","journal-title":"Hepatology"},{"key":"7720_CR17","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/s41388-024-03056-7","volume":"43","author":"X Li","year":"2024","unstructured":"Li X, He W, Chen X, Zhang Y, Zhang J, Liu F, et al. TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation. Oncogene. 2024;43:2063\u201377.","journal-title":"Oncogene"},{"key":"7720_CR18","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.7150\/ijbs.69495","volume":"18","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yao Y, Liao B, Zhang H, Yang Z, Xia P, et al. A positive feedback loop of CENPU\/E2F6\/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma. International J Biol Sci. 2022;18:4071\u201387.","journal-title":"International J Biol Sci"},{"key":"7720_CR19","doi-asserted-by":"publisher","unstructured":"He W, Wang M, Zhang X, Wang Y, Zhao D, Li W, et al. Estrogen induces LCAT to maintain cholesterol homeostasis and suppress hepatocellular carcinoma development. Cancer Res. 2024. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-3966.","DOI":"10.1158\/0008-5472.CAN-23-3966"},{"key":"7720_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/cac2.12403","volume":"43","author":"P Xia","year":"2023","unstructured":"Xia P, Zhang H, Lu H, Xu K, Jiang X, Jiang Y, et al. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Cancer Commun. 2023;43:338\u201364.","journal-title":"Cancer Commun"},{"key":"7720_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00018-024-05114-5","volume":"81","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xia T, Xia Z, Zhou H, Li Z, Wang W, et al. KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3\/Akt\/mTOR pathway. Cell Mol Life Sci. 2024;81:96.","journal-title":"Cell Mol Life Sci"},{"key":"7720_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.canlet.2021.11.016","volume":"526","author":"S Tuntithavornwat","year":"2022","unstructured":"Tuntithavornwat S, Shea DJ, Wong BS, Guardia T, Lee SJ, Yankaskas CL, et al. Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer. Cancer Lett. 2022;526:155\u201367.","journal-title":"Cancer Lett"},{"key":"7720_CR23","doi-asserted-by":"publisher","unstructured":"Li J, Zhang W, Gao J, Du M, Li H, Li M, et al. E3 ubiquitin ligase UBR5 promotes the metastasis of pancreatic cancer via destabilizing F-Actin capping protein CAPZA1. Front Oncol. 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.634167.","DOI":"10.3389\/fonc.2021.634167"},{"key":"7720_CR24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/pmic.201300402","volume":"14","author":"C Iuga","year":"2014","unstructured":"Iuga C, Seicean A, Iancu C, Buiga R, Sappa PK, V\u00f6lker U, et al. Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma. Proteomics. 2014;14:945\u201355.","journal-title":"Proteomics"},{"key":"7720_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7150\/thno.36930","volume":"10","author":"S-J Zhao","year":"2020","unstructured":"Zhao S-J, Kong F-Q, Jie J, Li Q, Liu H, Xu A-D, et al. Macrophage MSR1 promotes BMSC osteogenic differentiation and M2-like polarization by activating PI3K\/AKT\/GSK3\u03b2\/\u03b2-catenin pathway. Theranostics. 2020;10:17\u201335.","journal-title":"Theranostics"},{"key":"7720_CR26","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.7150\/ijbs.74647","volume":"18","author":"W Xu","year":"2022","unstructured":"Xu W, Wu Y, Liu W, Anwaier A, Tian X, Su J, et al. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma. Int J Biol Sci. 2022;18:4884\u2013900.","journal-title":"Int J Biol Sci"},{"key":"7720_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12094-022-02922-8","volume":"25","author":"C Lu","year":"2022","unstructured":"Lu C, Zhang C. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3\/PI3K\/AKT pathway. Clin Transl Oncol. 2022;25:160\u201372.","journal-title":"Clin Transl Oncol"},{"key":"7720_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","volume":"623","author":"N Caronni","year":"2023","unstructured":"Caronni N, La Terza F, Vittoria FM, Barbiera G, Mezzanzanica L, Cuzzola V, et al. IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer. Nature. 2023;623:415\u201322.","journal-title":"Nature"},{"key":"7720_CR29","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.ymthe.2020.11.024","volume":"29","author":"Y Yang","year":"2021","unstructured":"Yang Y, Guo Z, Chen W, Wang X, Cao M, Han X, et al. M2 Macrophage-derived exosomes promote angiogenesis and growth of pancreatic ductal adenocarcinoma by targeting E2F2. Mol Ther. 2021;29:1226\u201338.","journal-title":"Mol Ther"},{"key":"7720_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s13046-019-1313-x","volume":"38","author":"Z Yin","year":"2019","unstructured":"Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan J, et al. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-\u03b2 signaling pathway. J Exp Clin Cancer Res. 2019;38:310.","journal-title":"J Exp Clin Cancer Res"},{"key":"7720_CR31","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1053\/j.gastro.2022.02.024","volume":"162","author":"CJ Garcia Garcia","year":"2022","unstructured":"Garcia Garcia CJ, Huang Y, Fuentes NR, Turner MC, Monberg ME, Lin D, et al. Stromal HIF2 regulates immune suppression in the pancreatic cancer microenvironment. Gastroenterology. 2022;162:2018\u201331.","journal-title":"Gastroenterology"},{"key":"7720_CR32","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/j.gastro.2022.06.090","volume":"163","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, et al. An exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: a multicenter cohort study. Gastroenterology. 2022;163:1252\u201366.e2.","journal-title":"Gastroenterology"},{"key":"7720_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0975-5","volume":"18","author":"I Li","year":"2019","unstructured":"Li I, Nabet BY. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance. Mol Cancer. 2019;18:32.","journal-title":"Mol Cancer"},{"key":"7720_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00359-5","volume":"5","author":"E Yang","year":"2020","unstructured":"Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Sig Transduct Target Ther. 2020;5:1\u201313.","journal-title":"Sig Transduct Target Ther"},{"key":"7720_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215796","volume":"543","author":"Y Huang","year":"2022","unstructured":"Huang Y, Kanada M, Ye J, Deng Y, He Q, Lei Z, et al. Exosome-mediated remodeling of the tumor microenvironment: from local to distant intercellular communication. Cancer Lett. 2022;543:215796.","journal-title":"Cancer Lett"},{"key":"7720_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202209393","volume":"33","author":"P Xia","year":"2023","unstructured":"Xia P, Yuan H, Tian M, Zhong T, Hou R, Xu X, et al. Surface-engineered extracellular vesicles with CDH17 nanobodies to efficiently deliver imaging probes and chemo-photothermal drugs for gastric cancer theragnostic. Adv Funct Mater. 2023;33:2209393.","journal-title":"Adv Funct Mater"},{"key":"7720_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcancer.2021.05.029","volume":"86","author":"AJL Macario","year":"2022","unstructured":"Macario AJL, Conway de Macario E. Chaperonins in cancer: Expression, function, and migration in extracellular vesicles. Semin Cancer Biol. 2022;86:26\u201335.","journal-title":"Semin Cancer Biol"},{"key":"7720_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.yexcr.2015.02.005","volume":"332","author":"ST Guest","year":"2015","unstructured":"Guest ST, Kratche ZR, Bollig-Fischer A, Haddad R, Ethier SP. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes. Exp Cell Res. 2015;332:223\u201335.","journal-title":"Exp Cell Res"},{"key":"7720_CR39","doi-asserted-by":"publisher","unstructured":"Xu W-X, Song W, Jiang M-P, Yang S-J, Zhang J, Wang D-D, et al. Systematic characterization of expression profiles and prognostic values of the eight subunits of the chaperonin TRiC in breast cancer. Front Genetics. 2021;12. https:\/\/doi.org\/10.3389\/fgene.2021.637887.","DOI":"10.3389\/fgene.2021.637887"},{"key":"7720_CR40","doi-asserted-by":"publisher","unstructured":"Hallal S, Russell BP, Wei H, Lee MYT, Toon CW, Sy J, et al. Extracellular vesicles from neurosurgical aspirates identifies chaperonin containing TCP1 subunit 6A as a potential glioblastoma biomarker with prognostic significance. Proteomics. 2019;19. https:\/\/doi.org\/10.1002\/pmic.201800157.","DOI":"10.1002\/pmic.201800157"},{"key":"7720_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","journal-title":"Science"},{"key":"7720_CR42","doi-asserted-by":"publisher","first-page":"115087","DOI":"10.1016\/j.biopha.2023.115087","volume":"165","author":"J Li","year":"2023","unstructured":"Li J, Zhang Y, Dong P-Y, Yang G-M, Gurunathan S. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy. Biomed Pharmacother. 2023;165:115087.","journal-title":"Biomed Pharmacother"},{"key":"7720_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep42339","volume":"7","author":"M Mikamori","year":"2017","unstructured":"Mikamori M, Yamada D, Eguchi H, Hasegawa S, Kishimoto T, Tomimaru Y, et al. MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma. Sci Rep. 2017;7:42339.","journal-title":"Sci Rep"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07720-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T12:58:10Z","timestamp":1747313890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07720-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7720"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07720-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The procedures for patient sample collection and processing were carried out in accordance with the guidelines defined in the Declaration of Helsinki, with the approval of the Medical Ethical Committee of Zhongnan Hospital of Wuhan University (2024096K). All animal-related protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of the Wuhan University Center for Animal Experiments (WP20230660).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"382"}}